Skip to main content


Showing posts from October, 2022

Researchers Identify New Genes Linked With Schizophrenia Risk in First-of-Its-Kind Study

Researchers have made an important discovery about the causes of schizophrenia, a disease related to dementia or fragmented mentality.   Researchers have identified two genes associated with the disease as well as a third gene that carries the risk of schizophrenia and autism. Scientists involved in this research believes, this discovery can go a long way in finding a cure for these kind of diseases. Researchers at the Icahn School of Medicine found that these harmful genes are almost the same in every ethnic or racial group. The findings of this research were published in Nature Genetics . According to an estimate, about one percent of people worldwide suffering from schizophrenia. The scientists identified two risky genes, SRRM2 and AKAP11, based on a comparative analysis of gene sequencing from individuals with schizophrenia and healthy individuals. It compared a dataset of 35,828 patients with schizophrenia to 107,877 healthy or control groups and included a variety of

The Causes of Memory Loss Due to Breast Cancer Were Revealed

It is not enough to get rid of cancer. Cancer, and chemotherapy used for its treatment have long-term side effects. Even after getting cured of this disease, patients have to face many types of health related problems. Scientists are trying to find solutions to minimize the side effects of chemotherapy or systems used to treat cancer. One such problem is the loss of memory in patients after recovery from breast cancer. Scientists are trying to find out the reasons for this. Researchers from the University of California Los Angeles (UCLA) have succeeded in this matter. According to research published in the Journal of Clinical Oncology , the relation between memory loss or decline in inflammation during treatment has been found. According to the findings of this research, cancer patients who have recovered from breast cancer, whose memory is impaired, have higher levels of inflammatory Marker-C Reactive Protein (CRP). Judith Carroll, lead author of the research and associat